Table 1.

Baseline characteristics by affected coronary vessels at the coronary angiogram.

NumbersAll patientsNormal1-vessel (excl. LM)2-vessel (excl. LM)3-vessel (excl. LM)Left main stem (LM)p-Value
Angiographic findings %, (n)277620.9 (580)23.1 (641)18.1 (503)29.4 (815)8.5 (237) < 0.001
Clinical characteristics
Age, years, mean, (range), SD277658 (19–88) SD 1153 (19–86) SD 1156 (25–86) SD 1158 (32–85) SD 1060 (34–85) SD 1063 (37–88) SD 10<0.001
Male, %, (n)277658.4 (1621)53.3 (309)58.5 (375)56.3 (283)60.5 (493)67.9 (161)0.002
BMI, kg/m2, mean, (range), SD236026.4 (15.4–74.5) SD 4.426.8 (16.9–74.5) SD 5.326.5 (17.3–52.8) SD 4.326.5 (16.9–43.5) SD 4.226.2 (15.4 –42.5) SD 4.226.1 (16.2–40.3) SD 4.10.137
Smoker, current, %, (n)225415.0 (339)14.3 (64)16.9 (98)19.0 (80)13.2 (82)8.3 (15)<0.001
Systolic blood pressure, mm Hg, mean, (range), SD2575136 (84–220) SD 18134 (84–200) SD 18136 (90–214) SD 18136 (90–210) SD 17138 (85–220) SD18137  (100–190) SD 170.001
Diastolic blood pressure, mm Hg, mean, (range), SD257573 (40–115) SD 1074 (40–105) SD 1073 (50–115) SD1074 (48–110) SD 1072 (40–108) SD 1071 (40–102) SD 10<0.001
Hypertension, treated, %, (n)263980.4 (2121)68.7 (375)80.3 (480)82.6 (398)85.5 (671)86.4 (197)<0.001
Antihypertensive medication, %, (n)276680.5 (2236)82.9 (481)79.7 (511)80.5 (405)79.4 (647)81.0 (192)0.788
Hyperlipidaemia, treated, %, (n)224768.0 (1528)60.4 (271)62.2 (361)69.9 (290)74.4 (462)79.4 (143)<0.001
Atrial fibrillation, %, (n)27765.2 (144)6.9 (40)4.2 (27)3.0 (15)5.6 (46)6.8 (16)0.025
Previous disease, %, (n)
Myocardialinfarction277638.5 (1069)15.9 (92)33.2 (213)42.5 (214)51.2 (417)56.1 (133)<0.001
Any CAD277658.0 (1610)31.6 (183)52.6 (337)63.6 (320)72.3 (589)76.4 (181)<0.001
Previous PCI26175.8 (153)2.6 (14)5.7 (35)7.1 (34)7.4 (56)6.3 (14)0.022
Previous CABG277610.5 (291)1.2 (7)3.0 (19)5.0 (25)21.3 (174)27.8 (66)<0.001
Previous angina277635.4 (982)19.8 (115)28.7 (184)35.6 (179)47.5 (387)49.4 (117)<0.001
Heart failure277614.9 (414)11.4 (66)7.8 (50)13.5 (68)21.1 (172)24.5 (58)<0.001
Stroke27768.3 (231)5.7 (33)6.2 (40)8.5 (43)9.9 (81)14.3 (34)<0.001
Renal insufficiency277611.0 (306)12.9 (75)9.7 (62)11.7 (59)11.0 (90)8.4 (20)0.266
Peripheral artery diseasea277616.3 (452)9.1 (53)10.5 (67)17.5 (88)22.3 (182)26.2 (62)<0.001
Diabetes-related variables
HbA1c, mmol/mol, mean, (range), SD263866.7 (26–145) SD 14.165.6 (29–123) SD 14.866.8 (26–145) SD 14.367.4 (28–130) SD 13.767.2 (33–133) SD 13.565.7 (33–110) SD 13.90.162
Diabetes duration, years, mean, (range), SD277635 (0–76) SD 1429 (0–76) SD 1433 (0–69) SD 1435 (0–73) SD 1439 (5–70) SD 1342 (8–75) SD 14<0.001
Debute age, years, mean, (range), SD277623 (0–50) SD 1324 (0–50) SD 1423 (1–50) SD 1323 (0–50) SD 1321 (1–50) SD 1322 (0–50) SD 140.001
Creatinine, µmol/l, mean, (range), SD2524121 (24–1013) SD 128140 (34–1013) SD 177113 (24–938) SD 114118 (37–872) SD 117117 (40–971) SD 107114 (45–761) SD 960.003
LDL, mg/dl, mean, (range), SD18402.7 (0.5–7.3) SD 0.92.6 (0.6–6.0) SD 0.82.7 (0.9–7.3) SD 0.92.7 (0.5–7.3) SD 0.92.7 (0.6–6.0) SD 0.92.7 (0.7–7.0) SD 0.90.275
HDL, mg/dl, mean, (range), SD18611.52 (0.43–3.97) SD 0.491.60 (0.43–3.8) SD 0.521.53 (0.60–3.40) SD 0.481.46 (0.52–2.80) SD 0.451.52 (0.64–3.97) SD 0.501.45 (0.59–3.56) SD 0.480.002
Triglycerides, mg/dl, mean, (range), SD18591.39 (0.30–14.10) SD 1.021.27 (0.30–9.60) SD 0.871.44 (0.38–11.20), SD 1.111.47 (0.30–10.0) SD1.021.40 (0.40–13.0) SD 0.961.43 (0.40–14.10) SD 1.270.064
Retinopathy, %, (n)277666.1 (1836)60.0 (348)63.8 (409)65.8 (331)71.2 (580)70.9 (168)<0.001
Never hypo-glycaemia, %, (n)59689.8 (535)90.6 (126)93.8 (151)89.7 (96)85.0 (119)87.8 (43)0.121
Pump, %, (n)203312.2 (248)17.6 (77)12.0 (59)9.7 (35)12.3 (71)3.6 (6)<0.001
Never physical activity, %, (n)137815.2 (209)12.9 (38)14.2 (50)14.2 (33)17.5 (68)18.5 (20)0.255
Micro albuminuria, %, (n)227646.8 (1065)40.1 (190)42.7 (223)49.9 (205)51.0 (346)52.9 (101)<0.001
Macro albuminuria, %, (n)231823.5 (544)23.4 (110)20.6 (109)24.6 (103)24.3 (169)25.7 (53)0.478
Angio indication, %, (n)2752<0.001
Stable31.3 (862)22.6 (129)27.7 (177)30.8 (154)38.7 (311)38.4 (91)
NSTE-ACS37.5 (1032)23.8 (136)37.2 (238)41.2 (206)42.3 (340)47.3 (112)
STEMI10.2 (280)2.1 (12)17.7 (113)12.8 (64)9.6 (77)5.9 (14)
Chest pain5.4 (135)19.1 (109)1.7 (11)1.6 (8)0.7 (6)0.4 (1)
Silent IHD2.9 (81)4.2 (24)2.7 (17)3.6 (18)2.4 (19)1.3 (3)
Arrhythmia1.3 (36)4.5 (26)0.6 (4)0.6 (3)0.2 (2)0.4 (1)
Valvular3.6 (98)8.0 (46)4.2 (27)2.4 (12)1.0 (8)2.1 (5)
Heart failure3.6 (100)7.5 (43)2.8 (18)2.8 (14)2.5 (20)2.1 (5)
Aorta aneurysm0 (1)0.2 (1)0 (0)0 (0)0 (0)0 (0)
Cardiac arrest0.4 (10)0.5 (3)0.3 (2)0.4 (2)0.2 (2)0.4 (1)
Stent
Numbers, mean, (range), SD9931.2 (0–5) SD 0.90.3 (0–3) SD 0.71.1 (0–4) SD 0.71.3 (0–4) SD 0.91.3 (0–5) SD 1.11.3 (0–5) SD 1.3<0.001
Complete revascularisation after PCI, %, (n)87658.8 (515)77.8 (7)90.2 (360)40.6 (103)20.7 (36)22.5 (9)<0.001
Primary decision after angiography, %, (n)2698<0.001
No therapy9.7 (263)38.8 (222)3.2 (20)1.6 (8)1.1 (9)1.8 (4)
Medical19.5 (525)39.7 (227)15.6 (98)11.1 (54)14.8 (116)13.2 (30)
CABG19.8 (535)0 (0)1.4 (9)11.3 (55)44.1 (346)55.1 (125)
PCI36.2 (976)3.8 (22)68.6 (430)58.2 (284)25.3 (198)18.5 (42)
NumbersAll patientsNormal1-vessel (excl. LM)2-vessel (excl. LM)3-vessel (excl. LM)Left main stem (LM)p-Value
Angiographic findings %, (n)277620.9 (580)23.1 (641)18.1 (503)29.4 (815)8.5 (237) < 0.001
Clinical characteristics
Age, years, mean, (range), SD277658 (19–88) SD 1153 (19–86) SD 1156 (25–86) SD 1158 (32–85) SD 1060 (34–85) SD 1063 (37–88) SD 10<0.001
Male, %, (n)277658.4 (1621)53.3 (309)58.5 (375)56.3 (283)60.5 (493)67.9 (161)0.002
BMI, kg/m2, mean, (range), SD236026.4 (15.4–74.5) SD 4.426.8 (16.9–74.5) SD 5.326.5 (17.3–52.8) SD 4.326.5 (16.9–43.5) SD 4.226.2 (15.4 –42.5) SD 4.226.1 (16.2–40.3) SD 4.10.137
Smoker, current, %, (n)225415.0 (339)14.3 (64)16.9 (98)19.0 (80)13.2 (82)8.3 (15)<0.001
Systolic blood pressure, mm Hg, mean, (range), SD2575136 (84–220) SD 18134 (84–200) SD 18136 (90–214) SD 18136 (90–210) SD 17138 (85–220) SD18137  (100–190) SD 170.001
Diastolic blood pressure, mm Hg, mean, (range), SD257573 (40–115) SD 1074 (40–105) SD 1073 (50–115) SD1074 (48–110) SD 1072 (40–108) SD 1071 (40–102) SD 10<0.001
Hypertension, treated, %, (n)263980.4 (2121)68.7 (375)80.3 (480)82.6 (398)85.5 (671)86.4 (197)<0.001
Antihypertensive medication, %, (n)276680.5 (2236)82.9 (481)79.7 (511)80.5 (405)79.4 (647)81.0 (192)0.788
Hyperlipidaemia, treated, %, (n)224768.0 (1528)60.4 (271)62.2 (361)69.9 (290)74.4 (462)79.4 (143)<0.001
Atrial fibrillation, %, (n)27765.2 (144)6.9 (40)4.2 (27)3.0 (15)5.6 (46)6.8 (16)0.025
Previous disease, %, (n)
Myocardialinfarction277638.5 (1069)15.9 (92)33.2 (213)42.5 (214)51.2 (417)56.1 (133)<0.001
Any CAD277658.0 (1610)31.6 (183)52.6 (337)63.6 (320)72.3 (589)76.4 (181)<0.001
Previous PCI26175.8 (153)2.6 (14)5.7 (35)7.1 (34)7.4 (56)6.3 (14)0.022
Previous CABG277610.5 (291)1.2 (7)3.0 (19)5.0 (25)21.3 (174)27.8 (66)<0.001
Previous angina277635.4 (982)19.8 (115)28.7 (184)35.6 (179)47.5 (387)49.4 (117)<0.001
Heart failure277614.9 (414)11.4 (66)7.8 (50)13.5 (68)21.1 (172)24.5 (58)<0.001
Stroke27768.3 (231)5.7 (33)6.2 (40)8.5 (43)9.9 (81)14.3 (34)<0.001
Renal insufficiency277611.0 (306)12.9 (75)9.7 (62)11.7 (59)11.0 (90)8.4 (20)0.266
Peripheral artery diseasea277616.3 (452)9.1 (53)10.5 (67)17.5 (88)22.3 (182)26.2 (62)<0.001
Diabetes-related variables
HbA1c, mmol/mol, mean, (range), SD263866.7 (26–145) SD 14.165.6 (29–123) SD 14.866.8 (26–145) SD 14.367.4 (28–130) SD 13.767.2 (33–133) SD 13.565.7 (33–110) SD 13.90.162
Diabetes duration, years, mean, (range), SD277635 (0–76) SD 1429 (0–76) SD 1433 (0–69) SD 1435 (0–73) SD 1439 (5–70) SD 1342 (8–75) SD 14<0.001
Debute age, years, mean, (range), SD277623 (0–50) SD 1324 (0–50) SD 1423 (1–50) SD 1323 (0–50) SD 1321 (1–50) SD 1322 (0–50) SD 140.001
Creatinine, µmol/l, mean, (range), SD2524121 (24–1013) SD 128140 (34–1013) SD 177113 (24–938) SD 114118 (37–872) SD 117117 (40–971) SD 107114 (45–761) SD 960.003
LDL, mg/dl, mean, (range), SD18402.7 (0.5–7.3) SD 0.92.6 (0.6–6.0) SD 0.82.7 (0.9–7.3) SD 0.92.7 (0.5–7.3) SD 0.92.7 (0.6–6.0) SD 0.92.7 (0.7–7.0) SD 0.90.275
HDL, mg/dl, mean, (range), SD18611.52 (0.43–3.97) SD 0.491.60 (0.43–3.8) SD 0.521.53 (0.60–3.40) SD 0.481.46 (0.52–2.80) SD 0.451.52 (0.64–3.97) SD 0.501.45 (0.59–3.56) SD 0.480.002
Triglycerides, mg/dl, mean, (range), SD18591.39 (0.30–14.10) SD 1.021.27 (0.30–9.60) SD 0.871.44 (0.38–11.20), SD 1.111.47 (0.30–10.0) SD1.021.40 (0.40–13.0) SD 0.961.43 (0.40–14.10) SD 1.270.064
Retinopathy, %, (n)277666.1 (1836)60.0 (348)63.8 (409)65.8 (331)71.2 (580)70.9 (168)<0.001
Never hypo-glycaemia, %, (n)59689.8 (535)90.6 (126)93.8 (151)89.7 (96)85.0 (119)87.8 (43)0.121
Pump, %, (n)203312.2 (248)17.6 (77)12.0 (59)9.7 (35)12.3 (71)3.6 (6)<0.001
Never physical activity, %, (n)137815.2 (209)12.9 (38)14.2 (50)14.2 (33)17.5 (68)18.5 (20)0.255
Micro albuminuria, %, (n)227646.8 (1065)40.1 (190)42.7 (223)49.9 (205)51.0 (346)52.9 (101)<0.001
Macro albuminuria, %, (n)231823.5 (544)23.4 (110)20.6 (109)24.6 (103)24.3 (169)25.7 (53)0.478
Angio indication, %, (n)2752<0.001
Stable31.3 (862)22.6 (129)27.7 (177)30.8 (154)38.7 (311)38.4 (91)
NSTE-ACS37.5 (1032)23.8 (136)37.2 (238)41.2 (206)42.3 (340)47.3 (112)
STEMI10.2 (280)2.1 (12)17.7 (113)12.8 (64)9.6 (77)5.9 (14)
Chest pain5.4 (135)19.1 (109)1.7 (11)1.6 (8)0.7 (6)0.4 (1)
Silent IHD2.9 (81)4.2 (24)2.7 (17)3.6 (18)2.4 (19)1.3 (3)
Arrhythmia1.3 (36)4.5 (26)0.6 (4)0.6 (3)0.2 (2)0.4 (1)
Valvular3.6 (98)8.0 (46)4.2 (27)2.4 (12)1.0 (8)2.1 (5)
Heart failure3.6 (100)7.5 (43)2.8 (18)2.8 (14)2.5 (20)2.1 (5)
Aorta aneurysm0 (1)0.2 (1)0 (0)0 (0)0 (0)0 (0)
Cardiac arrest0.4 (10)0.5 (3)0.3 (2)0.4 (2)0.2 (2)0.4 (1)
Stent
Numbers, mean, (range), SD9931.2 (0–5) SD 0.90.3 (0–3) SD 0.71.1 (0–4) SD 0.71.3 (0–4) SD 0.91.3 (0–5) SD 1.11.3 (0–5) SD 1.3<0.001
Complete revascularisation after PCI, %, (n)87658.8 (515)77.8 (7)90.2 (360)40.6 (103)20.7 (36)22.5 (9)<0.001
Primary decision after angiography, %, (n)2698<0.001
No therapy9.7 (263)38.8 (222)3.2 (20)1.6 (8)1.1 (9)1.8 (4)
Medical19.5 (525)39.7 (227)15.6 (98)11.1 (54)14.8 (116)13.2 (30)
CABG19.8 (535)0 (0)1.4 (9)11.3 (55)44.1 (346)55.1 (125)
PCI36.2 (976)3.8 (22)68.6 (430)58.2 (284)25.3 (198)18.5 (42)

BMI: body mass index; CAD: coronary artery disease; CABG: coronary artery bypass graft; HbA1c: glycated haemoglobin; IHD: ischaemic heart disease; LM: left main-vessel disease; LDL: low density lipoprotein; HDL: high density lipoprotein; NSTE-ACS: non-ST-elevation acute coronary syndrome; PCI: percutaneous coronary intervention; SD: standard deviation; STEMI: ST-elevation myocardial infarction.

a

Hospitalisation for.

Table 1.

Baseline characteristics by affected coronary vessels at the coronary angiogram.

NumbersAll patientsNormal1-vessel (excl. LM)2-vessel (excl. LM)3-vessel (excl. LM)Left main stem (LM)p-Value
Angiographic findings %, (n)277620.9 (580)23.1 (641)18.1 (503)29.4 (815)8.5 (237) < 0.001
Clinical characteristics
Age, years, mean, (range), SD277658 (19–88) SD 1153 (19–86) SD 1156 (25–86) SD 1158 (32–85) SD 1060 (34–85) SD 1063 (37–88) SD 10<0.001
Male, %, (n)277658.4 (1621)53.3 (309)58.5 (375)56.3 (283)60.5 (493)67.9 (161)0.002
BMI, kg/m2, mean, (range), SD236026.4 (15.4–74.5) SD 4.426.8 (16.9–74.5) SD 5.326.5 (17.3–52.8) SD 4.326.5 (16.9–43.5) SD 4.226.2 (15.4 –42.5) SD 4.226.1 (16.2–40.3) SD 4.10.137
Smoker, current, %, (n)225415.0 (339)14.3 (64)16.9 (98)19.0 (80)13.2 (82)8.3 (15)<0.001
Systolic blood pressure, mm Hg, mean, (range), SD2575136 (84–220) SD 18134 (84–200) SD 18136 (90–214) SD 18136 (90–210) SD 17138 (85–220) SD18137  (100–190) SD 170.001
Diastolic blood pressure, mm Hg, mean, (range), SD257573 (40–115) SD 1074 (40–105) SD 1073 (50–115) SD1074 (48–110) SD 1072 (40–108) SD 1071 (40–102) SD 10<0.001
Hypertension, treated, %, (n)263980.4 (2121)68.7 (375)80.3 (480)82.6 (398)85.5 (671)86.4 (197)<0.001
Antihypertensive medication, %, (n)276680.5 (2236)82.9 (481)79.7 (511)80.5 (405)79.4 (647)81.0 (192)0.788
Hyperlipidaemia, treated, %, (n)224768.0 (1528)60.4 (271)62.2 (361)69.9 (290)74.4 (462)79.4 (143)<0.001
Atrial fibrillation, %, (n)27765.2 (144)6.9 (40)4.2 (27)3.0 (15)5.6 (46)6.8 (16)0.025
Previous disease, %, (n)
Myocardialinfarction277638.5 (1069)15.9 (92)33.2 (213)42.5 (214)51.2 (417)56.1 (133)<0.001
Any CAD277658.0 (1610)31.6 (183)52.6 (337)63.6 (320)72.3 (589)76.4 (181)<0.001
Previous PCI26175.8 (153)2.6 (14)5.7 (35)7.1 (34)7.4 (56)6.3 (14)0.022
Previous CABG277610.5 (291)1.2 (7)3.0 (19)5.0 (25)21.3 (174)27.8 (66)<0.001
Previous angina277635.4 (982)19.8 (115)28.7 (184)35.6 (179)47.5 (387)49.4 (117)<0.001
Heart failure277614.9 (414)11.4 (66)7.8 (50)13.5 (68)21.1 (172)24.5 (58)<0.001
Stroke27768.3 (231)5.7 (33)6.2 (40)8.5 (43)9.9 (81)14.3 (34)<0.001
Renal insufficiency277611.0 (306)12.9 (75)9.7 (62)11.7 (59)11.0 (90)8.4 (20)0.266
Peripheral artery diseasea277616.3 (452)9.1 (53)10.5 (67)17.5 (88)22.3 (182)26.2 (62)<0.001
Diabetes-related variables
HbA1c, mmol/mol, mean, (range), SD263866.7 (26–145) SD 14.165.6 (29–123) SD 14.866.8 (26–145) SD 14.367.4 (28–130) SD 13.767.2 (33–133) SD 13.565.7 (33–110) SD 13.90.162
Diabetes duration, years, mean, (range), SD277635 (0–76) SD 1429 (0–76) SD 1433 (0–69) SD 1435 (0–73) SD 1439 (5–70) SD 1342 (8–75) SD 14<0.001
Debute age, years, mean, (range), SD277623 (0–50) SD 1324 (0–50) SD 1423 (1–50) SD 1323 (0–50) SD 1321 (1–50) SD 1322 (0–50) SD 140.001
Creatinine, µmol/l, mean, (range), SD2524121 (24–1013) SD 128140 (34–1013) SD 177113 (24–938) SD 114118 (37–872) SD 117117 (40–971) SD 107114 (45–761) SD 960.003
LDL, mg/dl, mean, (range), SD18402.7 (0.5–7.3) SD 0.92.6 (0.6–6.0) SD 0.82.7 (0.9–7.3) SD 0.92.7 (0.5–7.3) SD 0.92.7 (0.6–6.0) SD 0.92.7 (0.7–7.0) SD 0.90.275
HDL, mg/dl, mean, (range), SD18611.52 (0.43–3.97) SD 0.491.60 (0.43–3.8) SD 0.521.53 (0.60–3.40) SD 0.481.46 (0.52–2.80) SD 0.451.52 (0.64–3.97) SD 0.501.45 (0.59–3.56) SD 0.480.002
Triglycerides, mg/dl, mean, (range), SD18591.39 (0.30–14.10) SD 1.021.27 (0.30–9.60) SD 0.871.44 (0.38–11.20), SD 1.111.47 (0.30–10.0) SD1.021.40 (0.40–13.0) SD 0.961.43 (0.40–14.10) SD 1.270.064
Retinopathy, %, (n)277666.1 (1836)60.0 (348)63.8 (409)65.8 (331)71.2 (580)70.9 (168)<0.001
Never hypo-glycaemia, %, (n)59689.8 (535)90.6 (126)93.8 (151)89.7 (96)85.0 (119)87.8 (43)0.121
Pump, %, (n)203312.2 (248)17.6 (77)12.0 (59)9.7 (35)12.3 (71)3.6 (6)<0.001
Never physical activity, %, (n)137815.2 (209)12.9 (38)14.2 (50)14.2 (33)17.5 (68)18.5 (20)0.255
Micro albuminuria, %, (n)227646.8 (1065)40.1 (190)42.7 (223)49.9 (205)51.0 (346)52.9 (101)<0.001
Macro albuminuria, %, (n)231823.5 (544)23.4 (110)20.6 (109)24.6 (103)24.3 (169)25.7 (53)0.478
Angio indication, %, (n)2752<0.001
Stable31.3 (862)22.6 (129)27.7 (177)30.8 (154)38.7 (311)38.4 (91)
NSTE-ACS37.5 (1032)23.8 (136)37.2 (238)41.2 (206)42.3 (340)47.3 (112)
STEMI10.2 (280)2.1 (12)17.7 (113)12.8 (64)9.6 (77)5.9 (14)
Chest pain5.4 (135)19.1 (109)1.7 (11)1.6 (8)0.7 (6)0.4 (1)
Silent IHD2.9 (81)4.2 (24)2.7 (17)3.6 (18)2.4 (19)1.3 (3)
Arrhythmia1.3 (36)4.5 (26)0.6 (4)0.6 (3)0.2 (2)0.4 (1)
Valvular3.6 (98)8.0 (46)4.2 (27)2.4 (12)1.0 (8)2.1 (5)
Heart failure3.6 (100)7.5 (43)2.8 (18)2.8 (14)2.5 (20)2.1 (5)
Aorta aneurysm0 (1)0.2 (1)0 (0)0 (0)0 (0)0 (0)
Cardiac arrest0.4 (10)0.5 (3)0.3 (2)0.4 (2)0.2 (2)0.4 (1)
Stent
Numbers, mean, (range), SD9931.2 (0–5) SD 0.90.3 (0–3) SD 0.71.1 (0–4) SD 0.71.3 (0–4) SD 0.91.3 (0–5) SD 1.11.3 (0–5) SD 1.3<0.001
Complete revascularisation after PCI, %, (n)87658.8 (515)77.8 (7)90.2 (360)40.6 (103)20.7 (36)22.5 (9)<0.001
Primary decision after angiography, %, (n)2698<0.001
No therapy9.7 (263)38.8 (222)3.2 (20)1.6 (8)1.1 (9)1.8 (4)
Medical19.5 (525)39.7 (227)15.6 (98)11.1 (54)14.8 (116)13.2 (30)
CABG19.8 (535)0 (0)1.4 (9)11.3 (55)44.1 (346)55.1 (125)
PCI36.2 (976)3.8 (22)68.6 (430)58.2 (284)25.3 (198)18.5 (42)
NumbersAll patientsNormal1-vessel (excl. LM)2-vessel (excl. LM)3-vessel (excl. LM)Left main stem (LM)p-Value
Angiographic findings %, (n)277620.9 (580)23.1 (641)18.1 (503)29.4 (815)8.5 (237) < 0.001
Clinical characteristics
Age, years, mean, (range), SD277658 (19–88) SD 1153 (19–86) SD 1156 (25–86) SD 1158 (32–85) SD 1060 (34–85) SD 1063 (37–88) SD 10<0.001
Male, %, (n)277658.4 (1621)53.3 (309)58.5 (375)56.3 (283)60.5 (493)67.9 (161)0.002
BMI, kg/m2, mean, (range), SD236026.4 (15.4–74.5) SD 4.426.8 (16.9–74.5) SD 5.326.5 (17.3–52.8) SD 4.326.5 (16.9–43.5) SD 4.226.2 (15.4 –42.5) SD 4.226.1 (16.2–40.3) SD 4.10.137
Smoker, current, %, (n)225415.0 (339)14.3 (64)16.9 (98)19.0 (80)13.2 (82)8.3 (15)<0.001
Systolic blood pressure, mm Hg, mean, (range), SD2575136 (84–220) SD 18134 (84–200) SD 18136 (90–214) SD 18136 (90–210) SD 17138 (85–220) SD18137  (100–190) SD 170.001
Diastolic blood pressure, mm Hg, mean, (range), SD257573 (40–115) SD 1074 (40–105) SD 1073 (50–115) SD1074 (48–110) SD 1072 (40–108) SD 1071 (40–102) SD 10<0.001
Hypertension, treated, %, (n)263980.4 (2121)68.7 (375)80.3 (480)82.6 (398)85.5 (671)86.4 (197)<0.001
Antihypertensive medication, %, (n)276680.5 (2236)82.9 (481)79.7 (511)80.5 (405)79.4 (647)81.0 (192)0.788
Hyperlipidaemia, treated, %, (n)224768.0 (1528)60.4 (271)62.2 (361)69.9 (290)74.4 (462)79.4 (143)<0.001
Atrial fibrillation, %, (n)27765.2 (144)6.9 (40)4.2 (27)3.0 (15)5.6 (46)6.8 (16)0.025
Previous disease, %, (n)
Myocardialinfarction277638.5 (1069)15.9 (92)33.2 (213)42.5 (214)51.2 (417)56.1 (133)<0.001
Any CAD277658.0 (1610)31.6 (183)52.6 (337)63.6 (320)72.3 (589)76.4 (181)<0.001
Previous PCI26175.8 (153)2.6 (14)5.7 (35)7.1 (34)7.4 (56)6.3 (14)0.022
Previous CABG277610.5 (291)1.2 (7)3.0 (19)5.0 (25)21.3 (174)27.8 (66)<0.001
Previous angina277635.4 (982)19.8 (115)28.7 (184)35.6 (179)47.5 (387)49.4 (117)<0.001
Heart failure277614.9 (414)11.4 (66)7.8 (50)13.5 (68)21.1 (172)24.5 (58)<0.001
Stroke27768.3 (231)5.7 (33)6.2 (40)8.5 (43)9.9 (81)14.3 (34)<0.001
Renal insufficiency277611.0 (306)12.9 (75)9.7 (62)11.7 (59)11.0 (90)8.4 (20)0.266
Peripheral artery diseasea277616.3 (452)9.1 (53)10.5 (67)17.5 (88)22.3 (182)26.2 (62)<0.001
Diabetes-related variables
HbA1c, mmol/mol, mean, (range), SD263866.7 (26–145) SD 14.165.6 (29–123) SD 14.866.8 (26–145) SD 14.367.4 (28–130) SD 13.767.2 (33–133) SD 13.565.7 (33–110) SD 13.90.162
Diabetes duration, years, mean, (range), SD277635 (0–76) SD 1429 (0–76) SD 1433 (0–69) SD 1435 (0–73) SD 1439 (5–70) SD 1342 (8–75) SD 14<0.001
Debute age, years, mean, (range), SD277623 (0–50) SD 1324 (0–50) SD 1423 (1–50) SD 1323 (0–50) SD 1321 (1–50) SD 1322 (0–50) SD 140.001
Creatinine, µmol/l, mean, (range), SD2524121 (24–1013) SD 128140 (34–1013) SD 177113 (24–938) SD 114118 (37–872) SD 117117 (40–971) SD 107114 (45–761) SD 960.003
LDL, mg/dl, mean, (range), SD18402.7 (0.5–7.3) SD 0.92.6 (0.6–6.0) SD 0.82.7 (0.9–7.3) SD 0.92.7 (0.5–7.3) SD 0.92.7 (0.6–6.0) SD 0.92.7 (0.7–7.0) SD 0.90.275
HDL, mg/dl, mean, (range), SD18611.52 (0.43–3.97) SD 0.491.60 (0.43–3.8) SD 0.521.53 (0.60–3.40) SD 0.481.46 (0.52–2.80) SD 0.451.52 (0.64–3.97) SD 0.501.45 (0.59–3.56) SD 0.480.002
Triglycerides, mg/dl, mean, (range), SD18591.39 (0.30–14.10) SD 1.021.27 (0.30–9.60) SD 0.871.44 (0.38–11.20), SD 1.111.47 (0.30–10.0) SD1.021.40 (0.40–13.0) SD 0.961.43 (0.40–14.10) SD 1.270.064
Retinopathy, %, (n)277666.1 (1836)60.0 (348)63.8 (409)65.8 (331)71.2 (580)70.9 (168)<0.001
Never hypo-glycaemia, %, (n)59689.8 (535)90.6 (126)93.8 (151)89.7 (96)85.0 (119)87.8 (43)0.121
Pump, %, (n)203312.2 (248)17.6 (77)12.0 (59)9.7 (35)12.3 (71)3.6 (6)<0.001
Never physical activity, %, (n)137815.2 (209)12.9 (38)14.2 (50)14.2 (33)17.5 (68)18.5 (20)0.255
Micro albuminuria, %, (n)227646.8 (1065)40.1 (190)42.7 (223)49.9 (205)51.0 (346)52.9 (101)<0.001
Macro albuminuria, %, (n)231823.5 (544)23.4 (110)20.6 (109)24.6 (103)24.3 (169)25.7 (53)0.478
Angio indication, %, (n)2752<0.001
Stable31.3 (862)22.6 (129)27.7 (177)30.8 (154)38.7 (311)38.4 (91)
NSTE-ACS37.5 (1032)23.8 (136)37.2 (238)41.2 (206)42.3 (340)47.3 (112)
STEMI10.2 (280)2.1 (12)17.7 (113)12.8 (64)9.6 (77)5.9 (14)
Chest pain5.4 (135)19.1 (109)1.7 (11)1.6 (8)0.7 (6)0.4 (1)
Silent IHD2.9 (81)4.2 (24)2.7 (17)3.6 (18)2.4 (19)1.3 (3)
Arrhythmia1.3 (36)4.5 (26)0.6 (4)0.6 (3)0.2 (2)0.4 (1)
Valvular3.6 (98)8.0 (46)4.2 (27)2.4 (12)1.0 (8)2.1 (5)
Heart failure3.6 (100)7.5 (43)2.8 (18)2.8 (14)2.5 (20)2.1 (5)
Aorta aneurysm0 (1)0.2 (1)0 (0)0 (0)0 (0)0 (0)
Cardiac arrest0.4 (10)0.5 (3)0.3 (2)0.4 (2)0.2 (2)0.4 (1)
Stent
Numbers, mean, (range), SD9931.2 (0–5) SD 0.90.3 (0–3) SD 0.71.1 (0–4) SD 0.71.3 (0–4) SD 0.91.3 (0–5) SD 1.11.3 (0–5) SD 1.3<0.001
Complete revascularisation after PCI, %, (n)87658.8 (515)77.8 (7)90.2 (360)40.6 (103)20.7 (36)22.5 (9)<0.001
Primary decision after angiography, %, (n)2698<0.001
No therapy9.7 (263)38.8 (222)3.2 (20)1.6 (8)1.1 (9)1.8 (4)
Medical19.5 (525)39.7 (227)15.6 (98)11.1 (54)14.8 (116)13.2 (30)
CABG19.8 (535)0 (0)1.4 (9)11.3 (55)44.1 (346)55.1 (125)
PCI36.2 (976)3.8 (22)68.6 (430)58.2 (284)25.3 (198)18.5 (42)

BMI: body mass index; CAD: coronary artery disease; CABG: coronary artery bypass graft; HbA1c: glycated haemoglobin; IHD: ischaemic heart disease; LM: left main-vessel disease; LDL: low density lipoprotein; HDL: high density lipoprotein; NSTE-ACS: non-ST-elevation acute coronary syndrome; PCI: percutaneous coronary intervention; SD: standard deviation; STEMI: ST-elevation myocardial infarction.

a

Hospitalisation for.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close